In this protocol, it is essential to proceed with the tissue processing and embedding steps immediately after collection. The blocks and slides of tissue, however, can be kept for at least 3 months at -20 °C. Several steps in this protocol can be modified to suit different applications, in particular, section thickness, magnification, and z-stack parameters. This will impact the depth of imaging and the resolution obtained. Changes in numerical aperture and resolution mode could be used to obtain an even higher resolution and the z-stacks interval size decreased. However, this would increase imaging time or reduce the size of the field of view that can be imaged. The imaging parameters described are the minimum requirements identified for 3D analysis of primary cilia orientation.
The choice of mounting medium is important to obtain high resolution. The refractive index of the mounting medium must be similar to that of the immersion medium to minimize image degradation in the z-stack. The refractive index of the mountant and the immersion oil used here have refractive indexes of 1.52 and 1.518, respectively. The Airyscan function on the confocal microscope used here offers super-resolution images. Other super-resolution microscopes could be used; however, we found that the confocal mode only was not sufficient to obtain the resolution required for the size of the areas imaged. The maximum resolution of the Multiplex SR-8Y Airyscan mode is 120/160 nm in x/y and 450 nm in z, and a maximum number of frames/s of 47.5. We found the Multiplex SR-4Y Airyscan mode, which presents a maximum resolution of 140 nm in x/y and 450 nm in z but images at half the speed with a maximum number of frames/s of 25, not to present a significant difference for imaging primary cilia in 3D. Similarly, the Airyscan super-resolution (SR) mode, which offers the highest resolution on this microscope -- 120 nm in x/y and 350 nm in z -- would take longer to image, as its maximum number of frames/s is 4.713.
Background GFP signal can be observed in other tissues such as the muscle. To minimize this, the range of the lasers can be narrowed to reduce overlap with other wavelengths. This line has previously been used to image primary cilia in the embryo, primary cell cultures, muscle fibers, and the retinal pigment epithelium9,14,15. We have successfully imaged primary cilia in kidney, cartilage, and bone tissue. Some optimization of imaging settings will likely be required for different tissues; however, this cryosection protocol should ensure preservation of the signal.
Two-cell thick sections (40-60 µm) sections are sufficient to obtain 3D orientation information in the growth plate, as this allows imaging of whole cells and their primary cilia. For other tissues where cells are larger than chondrocytes, such as adipocytes, thicker sections may be required to collect cell population data. Depending on the depth resolution of the microscope used, it may not be possible to image deep into thicker sections. Tissue clearing techniques would likely lead to loss of the endogenous mCherry and GFP signal due to the time it requires. This was explored, as clearing methods were used for other imaging in the limb but it was not found necessary in this context. Our experience with endogenous CD31-RFP suggested clearing techniques would need careful, bespoke to sample, optimization.
This ARL13B-CENTRIN-2 line can be crossed with other mouse lines to further study the organization of primary cilia in tissues. For example, we have crossed it with an aggrecan-Cre IFT88fl/fl to conditionally knock out IFT88, a primary cilia protein whose deletion prevents ciliation, in aggrecan-expressing cells (postnatal chondrocytes)5,6. These ARL13B and CENTRIN-2 fluorescent signals can then be used to measure the efficiency of genetic perturbations at the level of ciliary structure in tissues and any associated changes in ciliary organization. Ongoing work is currently doing exactly this. Our first aim will be to quantify, with this more robust methodology, the effect of IFT88 deletion on cilia prevalence. Previously, we have gauged this by using immunofluorescence and estimated this to be a 20% reduction6. This method can also be combined with immunohistochemistry to image primary cilia in combination with other proteins, for example, a cell membrane protein.
The transgene on ARL13B may have an effect on ARL13B expression and primary cilia length. Previous studies have measured different primary cilia lengths with the ARL13B-CENTRIN-2 line compared to non-transgene ARL13B in certain regions of the mouse brain, with no difference in others16. Another study observed differences in primary cilia length in a GFP-tagged ARL13B mouse line compared to untagged ARL13B in mouse embryonic fibroblasts10. Ongoing work is verifying any changes in primary cilia length in the growth plate and other tissues by comparing the results using the ARL13B-CENTRIN-2 mouse line with antibody staining against non-transgenic ARL13B.
The image analysis pipeline in this protocol was designed to subsequently measure the ciliation percentage, length, and 3D orientation of primary cilia, as well as centriole number and position in the growth plate. The image analysis software allows for custom pipelines to be made by changing the steps involved. The output of this pipeline is a spreadsheet with the measures of the chosen features for the cells, cilia, and centrioles detected. Postanalysis can then be performed in R or other software according to the purposes of the study. As with the imaging settings, the pipeline steps and specific settings can be changed to work on different images and according to the aims of the study. Overall, this method allows high-throughput analysis of primary cilia than has been published previously in the growth plate. The number of cells and associated cilia that can be studied allows for larger and more reliable measurements.